Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Assessment of Electrolyte Values in the Intensive Care Unit:Comparison Between Arterial and Venous Blood Gas Analysis and Formal Laboratory Testing
This study has been completed.
Sponsored by: Melbourne Health
Information provided by: Melbourne Health
ClinicalTrials.gov Identifier: NCT00256061
  Purpose

The study hypothesis is that in critically ill patients there is significant differences between electrolyte levels measured using blood gas analysers and by laboratory techniques, and between levels measured on arterial and venous blood samples.


Condition
Electrolyte Values

MedlinePlus related topics: Gas
U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Cross-Sectional, Defined Population, Prospective Study
Official Title: Assessment of Electrolyte Values in the Intensive Care Unit:Comparison Between Arterial and Venous Blood Gas Analysis and Formal Laboratory Testing

Further study details as provided by Melbourne Health:

Estimated Enrollment: 100
Study Start Date: February 2003
Estimated Study Completion Date: February 2004
Detailed Description:

The sudy hypothesis is that in critically ill patients there is a significant difference between electrolyte levels measured using blood gas analysers and by laboratory techniques, and between levels measured on arterial and venous blood samples.

The study aim is determine the agreement between electrolyte levels measure by formal laboratory serum analysis and point-of-care blood gas analysis.

Also, to determine the agreement between electrolyte levels measured on simultaneous arterial and venous blood samples, using both serum and whole blood samples.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Adult patients 18 years or older admitted to the intensive care unit
  2. Patients who have arterial and central venous access insitu for clinical management purposes.
  3. Patients who consent to inclusion in the study, or if the patient is not competent, the next of kins' consent.

Exclusion Criteria:

Nil-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00256061

Sponsors and Collaborators
Melbourne Health
Investigators
Principal Investigator: Megan Robertson, MBBS Royal Melbourne Hospital, Intensive Care Unit
  More Information

Study ID Numbers: 2002.229
Study First Received: November 17, 2005
Last Updated: November 17, 2005
ClinicalTrials.gov Identifier: NCT00256061  
Health Authority: Australia: Department of Health and Ageing Therapeutic Goods Administration

ClinicalTrials.gov processed this record on January 13, 2009



U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services